Skip to content
★ Sign in to follow
PB

Paul Buck

CFO
Emmaus Life Sciences, Inc.
Total declarations
9
Company
1
▲ Purchases (1 ops.)
€7,447
▼ Sales (0 ops.)
—

Latest filing published 07 Apr 2016 for Emmaus Life Sciences, Inc..

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Paul Buck: trading record in brief

Paul Buck discloses dealings in Emmaus Life Sciences, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 6 October 2011 to 5 April 2016.

The open-market record is one-sided, with 1 purchase worth €7,447 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 1 option exercise.

On 7 April 2016 came the latest disclosure, a share grant in Emmaus Life Sciences, Inc. The last insider purchase was made public on 11 October 2011, 5,508 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Paul Buck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations